<DOC>
	<DOCNO>NCT00096811</DOCNO>
	<brief_summary>The purpose clinical research study provide entecavir subject chronic Hepatitis B infection fail demonstrated intolerance market therapy use agent contraindicate available treatment option .</brief_summary>
	<brief_title>Entecavir Subjects With Chronic Hepatitis B Infection : An Early Access Program</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>Hepatitis B Early Access Program</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>